Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,648 | 8,558 | 10,840 | 12,573 | 0 |
| TOTAL | $6,686 | $8,646 | $10,925 | $12,603 | $0 |
| Non-Current Assets | |||||
| PPE Net | 362 | 365 | 93 | 28 | N/A |
| Other Non-Current Assets | 316 | 316 | 316 | 0 | 0 |
| TOTAL | $678 | $681 | $409 | $28 | $N/A |
| Total Assets | $7,363 | $9,327 | $11,334 | $12,631 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 281 | 242 | 397 | 261 | 0 |
| Accrued Expenses | 547 | 387 | 462 | 242 | 0 |
| TOTAL | $872 | $673 | $859 | $502 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $34 | $44 | $N/A | $N/A | $N/A |
| Total Liabilities | $906 | $717 | $859 | $502 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 640 | 640 | 640 | 630 | N/A |
| Common Shares | 3 | 3 | 3 | 3 | 0 |
| Retained earnings | -8,396 | -5,970 | -3,831 | -2,029 | 0 |
| TOTAL | $6,458 | $8,610 | $10,475 | $12,128 | $0 |
| Total Liabilities And Equity | $7,363 | $9,327 | $11,334 | $12,631 | $0 |